TickerFacts.

Pacific Biosciences of California, Inc. (PACB): Total Liabilities

Annual figures by period end, from SEC filings.

$778.73M
As of 2025-12-31
$785.06M
As of 2026-06-30
-13.5%
3-year compound annual growth
+58.2%
5-year compound annual growth
+29.8%
10-year compound annual growth
$1.22B2010-12-31: $25.88M2011-12-31: $26.85M2012-12-31: $20.30M2013-12-31: $67.00M2014-12-31: $69.44M2015-12-31: $57.57M2016-12-31: $53.22M2017-12-31: $57.98M2018-12-31: $56.21M2019-12-31: $93.07M2020-12-31: $78.49M2021-12-31: $1.22B2022-12-31: $1.20B2023-12-31: $1.04B2024-12-31: $753.85M2025-12-31: $778.73M$778.73M
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$778.73M+3.3%2026-02-25, Balance as of period end
2024-12-31$753.85M-27.8%2026-02-25, Balance as of period end
2023-12-31$1.04B-13.2%2025-03-17, Balance as of period end
2022-12-31$1.20B-1.0%2024-02-28, Balance as of period end
2021-12-31$1.22Bn/m2023-02-28, Balance as of period end
2020-12-31$78.49M-15.7%2022-02-28, Balance as of period end
2019-12-31$93.07M+65.6%2021-02-26, Balance as of period end
2018-12-31$56.21M-3.0%2020-02-28, Balance as of period end
2017-12-31$57.98M+9.0%2019-02-26, Balance as of period end
2016-12-31$53.22M-7.6%2018-02-26, Balance as of period end
2015-12-31$57.57M-17.1%2017-03-06, Balance as of period end
2014-12-31$69.44M+3.6%2016-03-11, Balance as of period end
2013-12-31$67.00M+230.1%2015-03-12, Balance as of period end
2012-12-31$20.30M-24.4%2014-03-14, Balance as of period end
2011-12-31$26.85M+3.8%2013-03-15, Balance as of period end
2010-12-31$25.88Mn/a2012-03-01, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Pacific Biosciences of California, Inc. (PACB)2025-12-31$778.73M+3.3%
Quanterix Corp (QTRX)2025-12-31$123.04M+60.8%
Cytek Biosciences, Inc. (CTKB)2025-12-31$119.80M+15.5%
Harvard Bioscience Inc (HBIO)2025-12-31$66.34M+4.8%
908 Devices Inc. (MASS)2025-12-31$46.37M+3.3%
10x Genomics, Inc. (TXG)2025-12-31$245.04M+17.5%
Rapid Micro Biosystems, Inc. (RPID)2025-12-31$41.65M+82.5%
EyePoint, Inc. (EYPT)2025-12-31$57.88M-29.4%
Bionano Genomics, Inc. (BNGO)2025-12-31$29.16M-29.4%

Compare PACB, QTRX, CTKB, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗